OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 131 filers reported holding OCULAR THERAPEUTIX INC in Q1 2022. The put-call ratio across all filers is 1.09 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $161,590 | -40.7% | 51,462 | -2.6% | 0.00% | -25.0% |
| Q2 2023 | $272,612 | -5.8% | 52,832 | -3.8% | 0.00% | -20.0% |
| Q1 2023 | $289,348 | +94.5% | 54,905 | +3.7% | 0.01% | +66.7% |
| Q4 2022 | $148,780 | -30.5% | 52,947 | +2.5% | 0.00% | -50.0% |
| Q3 2022 | $214,000 | +7.5% | 51,662 | +4.2% | 0.01% | +20.0% |
| Q2 2022 | $199,000 | -15.3% | 49,584 | +4.3% | 0.01% | 0.0% |
| Q1 2022 | $235,000 | -21.9% | 47,544 | +10.2% | 0.01% | -16.7% |
| Q4 2021 | $301,000 | -65.4% | 43,153 | -50.4% | 0.01% | -64.7% |
| Q3 2021 | $869,000 | – | 86,916 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |